Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Blood

Retrieve available abstracts of 255 articles:
HTML format
Text format



Single Articles


    May 2017
  1. KATSUYA H, Shimokawa M, Ishitsuka K, Kawai K, et al
    A prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma.
    Blood. 2017 May 17. pii: blood-2017-01-757542. doi: 10.1182/blood-2017-01-757542
    PubMed     Text format     Abstract available


  2. CHEN TL, Tran M, Lakshmanan A, Harrington BK, et al
    NF-kappaB p50 (nfkb1) contributes to pathogenesis in the Emu-TCL1 mouse model of chronic lymphocytic leukemia.
    Blood. 2017 May 17. pii: blood-2017-01-761130. doi: 10.1182/blood-2017-01-761130
    PubMed     Text format    


  3. SMITH CC, Paguirigan A, Jeschke GR, Lin KC, et al
    Heterogeneous resistance to quizartinib in acute myeloid leukemia (AML) revealed by single cell analysis.
    Blood. 2017 May 10. pii: blood-2016-04-711820. doi: 10.1182/blood-2016-04-711820
    PubMed     Text format     Abstract available


  4. XU J, Li S
    Triple-hit blastoid mantle cell lymphoma presenting like acute leukemia.
    Blood. 2017;129:2593.
    PubMed     Text format    


  5. GORINI F, Azzimonti L, Delfanti G, Scarfo L, et al
    Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis.
    Blood. 2017 May 2. pii: blood-2016-11-751065. doi: 10.1182/blood-2016-11-751065.
    PubMed     Text format     Abstract available


    April 2017
  6. KRUTH K, Fang M, Shelton DN, Abu-Halawa O, et al
    Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia.
    Blood. 2017 Apr 19. pii: blood-2017-02-766204. doi: 10.1182/blood-2017-02-766204
    PubMed     Text format     Abstract available


  7. DING W, LaPlant BR, Call TG, Parikh SA, et al
    Pembrolizumab in patients with chronic lymphocytic leukemia with Richter's transformation and relapsed CLL.
    Blood. 2017 Apr 19. pii: blood-2017-02-765685. doi: 10.1182/blood-2017-02-765685
    PubMed     Text format     Abstract available


  8. VUJKOVIC M, Attiyeh EF, Ries RE, Goodman EK, et al
    Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report.
    Blood. 2017 Apr 14. pii: blood-2017-03-772384. doi: 10.1182/blood-2017-03-772384
    PubMed     Text format     Abstract available


  9. GARDNER RA, Finney O, Annesley C, Brakke H, et al
    Intent to treat leukemia remission by CD19CAR T cells of defined formulation and dose in children and young adults.
    Blood. 2017 Apr 13. pii: blood-2017-02-769208. doi: 10.1182/blood-2017-02-769208
    PubMed     Text format     Abstract available


  10. HU S, Qian M, Zhang H, Guo Y, et al
    Whole-genome non-coding sequence analysis in T-cell acute lymphoblastic leukemia identifies oncogene enhancer mutations.
    Blood. 2017 Apr 13. pii: blood-2017-03-771162. doi: 10.1182/blood-2017-03-771162
    PubMed     Text format    



  11. Marks DI, Rowntree C. Management of adults with T-cell lymphoblastic leukemia. Blood. 2017;129(9):1134-1142.
    Blood. 2017;129:2204.
    PubMed     Text format    


  12. PORCHER C, Chagraoui H, Kristiansen MS
    SCL/TAL1: a multifaceted regulator from blood development to disease.
    Blood. 2017;129:2051-2060.
    PubMed     Text format     Abstract available


  13. SOOD R, Kamikubo Y, Liu P
    Role of RUNX1 in hematological malignancies.
    Blood. 2017;129:2070-2082.
    PubMed     Text format     Abstract available


  14. AVELLINO R, Delwel R
    Expression and regulation of C/EBPalpha in normal myelopoiesis and in malignant transformation.
    Blood. 2017;129:2083-2091.
    PubMed     Text format     Abstract available


  15. DE BRUIJN M, Dzierzak E
    Runx transcription factors in the development and function of the definitive hematopoietic system.
    Blood. 2017;129:2061-2069.
    PubMed     Text format     Abstract available


  16. UFFMANN M, Rasche M, Zimmermann M, von Neuhoff C, et al
    Therapy reduction in patients with Down Syndrome Myeloid Leukemia: The international ML-DS 2006 trial.
    Blood. 2017 Apr 11. pii: blood-2017-01-765057. doi: 10.1182/blood-2017-01-765057
    PubMed     Text format     Abstract available


  17. BELDERBOS ME, Koster T, Ausema B, Jacobs S, et al
    Clonal selection and asymmetric distribution of human leukemia in murine xenografts revealed by cellular barcoding.
    Blood. 2017 Apr 10. pii: blood-2016-12-758250. doi: 10.1182/blood-2016-12-758250
    PubMed     Text format     Abstract available


  18. TAUB JW, Berman JN, Hitzler JK, Sorrell AD, et al
    Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial.
    Blood. 2017 Apr 7. pii: blood-2017-01-764324. doi: 10.1182/blood-2017-01-764324.
    PubMed     Text format     Abstract available


    March 2017
  19. GARZON R, Savona M, Baz R, Andreeff M, et al
    A phase I clinical trial of single-agent selinexor in acute myeloid leukemia.
    Blood. 2017 Mar 23. pii: blood-2016-11-750158. doi: 10.1182/blood-2016-11-750158
    PubMed     Text format     Abstract available


  20. FISCHER K, Al-Sawaf O, Fink AM, Dixon M, et al
    Venetoclax and obinutuzumab in chronic lymphocytic leukemia.
    Blood. 2017 Mar 21. pii: blood-2017-01-761973. doi: 10.1182/blood-2017-01-761973
    PubMed     Text format    


  21. CHENG CK, Wang AZ, Wong TH, Wan TS, et al
    FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia.
    Blood. 2017 Mar 17. pii: blood-2017-02-767707. doi: 10.1182/blood-2017-02-767707
    PubMed     Text format    


  22. LOGHAVI S, Khoury JD
    Langerhans cell histiocytosis in a patient with hairy cell leukemia: a tale of divergence.
    Blood. 2017;129:1563.
    PubMed     Text format    


  23. HEIN N, Cameron DP, Hannan KM, Nguyen NN, et al
    Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population.
    Blood. 2017 Mar 10. pii: blood-2016-05-718171. doi: 10.1182/blood-2016-05-718171
    PubMed     Text format     Abstract available


  24. RAHMAN S, Magnussen M, Leon TE, Farah N, et al
    Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia.
    Blood. 2017 Mar 7. pii: blood-2016-09-742148. doi: 10.1182/blood-2016-09-742148.
    PubMed     Text format     Abstract available


  25. LAL R, Lind K, Heitzer E, Ulz P, et al
    Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia.
    Blood. 2017 Mar 3. pii: blood-2016-11-751008. doi: 10.1182/blood-2016-11-751008.
    PubMed     Text format    


    February 2017
  26. TASIAN SK, Kenderian SS, Shen F, Ruella M, et al
    Optimized Depletion of Chimeric Antigen Receptor T-Cells in Murine Xenograft Models of Human Acute Myeloid Leukemia.
    Blood. 2017 Feb 28. pii: blood-2016-08-736041. doi: 10.1182/blood-2016-08-736041
    PubMed     Text format     Abstract available


  27. MONTALBAN-BRAVO G, Benton CB, Wang SA, Ravandi F, et al
    Greater than one TP53 abnormality is a dominant characteristic of pure erythroid leukemia.
    Blood. 2017 Feb 28. pii: blood-2016-11-749903. doi: 10.1182/blood-2016-11-749903
    PubMed     Text format    


  28. DANESHBOD Y, Medeiros LJ
    Dermal myeloid sarcoma as an initial presentation of acute myeloid leukemia.
    Blood. 2017;129:1056.
    PubMed     Text format    


  29. NAUDIN C, Hattabi A, Michelet F, Miri-Nezhad A, et al
    PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.
    Blood. 2017 Feb 23. pii: blood-2016-10-747436. doi: 10.1182/blood-2016-10-747436
    PubMed     Text format     Abstract available


  30. YOSHIZATO T, Nannya Y, Atsuta Y, Shiozawa Y, et al
    Impact of genetic alterations in stem-cell transplantation for myelodysplasia and secondary acute myeloid leukemia.
    Blood. 2017 Feb 21. pii: blood-2016-12-754796. doi: 10.1182/blood-2016-12-754796
    PubMed     Text format     Abstract available


  31. NAKATA Y, Ueda T, Nagamachi A, Yamasaki N, et al
    Acquired expression of CblQ367P in mice induces dysplastic myelopoiesis mimicking chronic myelomonocytic leukemia.
    Blood. 2017 Feb 16. pii: blood-2016-06-724658. doi: 10.1182/blood-2016-06-724658
    PubMed     Text format     Abstract available


  32. MILNE TA
    Mouse models of MLL leukemia: recapitulating the human disease.
    Blood. 2017 Feb 8. pii: blood-2016-10-691428. doi: 10.1182/blood-2016-10-691428.
    PubMed     Text format     Abstract available


  33. CAMPANA D, Pui CH
    Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.
    Blood. 2017 Feb 6. pii: blood-2016-12-725804. doi: 10.1182/blood-2016-12-725804.
    PubMed     Text format    


  34. THOMAS D, Majeti R
    Biology and relevance of human acute myeloid leukemia stem cells.
    Blood. 2017 Feb 3. pii: blood-2016-10-696054. doi: 10.1182/blood-2016-10-696054.
    PubMed     Text format     Abstract available


  35. HOLYOAKE TL, Vetrie D
    The chronic myeloid leukemia stem cell: stemming the tide of persistence.
    Blood. 2017 Feb 3. pii: blood-2016-09-696013. doi: 10.1182/blood-2016-09-696013.
    PubMed     Text format     Abstract available


  36. POLLYEA DA, Jordan CT
    Therapeutic targeting of acute myeloid leukemia stem cells.
    Blood. 2017 Feb 3. pii: blood-2016-10-696039. doi: 10.1182/blood-2016-10-696039.
    PubMed     Text format     Abstract available


  37. GODWIN CD, McDonald GB, Walter RB
    Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia.
    Blood. 2017 Feb 2. pii: blood-2017-01-762419. doi: 10.1182/blood-2017-01-762419.
    PubMed     Text format    


    January 2017
  38. ISHIZAWA J, Sugihara E, Kuninaka S, Mogushi K, et al
    FZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B cell acute leukemia.
    Blood. 2017 Jan 31. pii: blood-2016-07-726216. doi: 10.1182/blood-2016-07-726216
    PubMed     Text format     Abstract available


  39. LAOUEDJ M, Tardif MR, Gil L, Raquil MA, et al
    S100A9 induces differentiation of acute myeloid leukemia cells through TLR4.
    Blood. 2017 Jan 30. pii: blood-2016-09-738005. doi: 10.1182/blood-2016-09-738005
    PubMed     Text format     Abstract available


  40. XU J, Li S
    Blasts with abundant cytoplasmic granules: acute myeloid leukemia or granular acute lymphoblastic leukemia?
    Blood. 2017;129:537.
    PubMed     Text format    


  41. GHIA P, Scarfo L, Perez S, Pathiraja K, et al
    Efficacy and safety of dinaciclib versus ofatumumab in patients with relapsed/refractory chronic lymphocytic leukemia.
    Blood. 2017 Jan 26. pii: blood-2016-10-748210. doi: 10.1182/blood-2016-10-748210
    PubMed     Text format    


  42. PYZER AR, Stroopinsky D, Rajabi H, Washington A, et al
    MUC1 mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.
    Blood. 2017 Jan 26. pii: blood-2016-07-730614. doi: 10.1182/blood-2016-07-730614
    PubMed     Text format     Abstract available


  43. BOCHTLER T, Granzow M, Stolzel F, Kunz C, et al
    Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia.
    Blood. 2017 Jan 24. pii: blood-2016-09-738161. doi: 10.1182/blood-2016-09-738161
    PubMed     Text format     Abstract available


  44. MARKS DI, Rowntree C
    A review of the management of adults with T-cell acute lymphoblastic leukemia.
    Blood. 2017 Jan 23. pii: blood-2016-07-692608. doi: 10.1182/blood-2016-07-692608
    PubMed     Text format     Abstract available


  45. SANCHEZ-MARTIN M, Ferrando A
    The NOTCH1-MYC highway towards T-cell acute lymphoblastic leukemia.
    Blood. 2017 Jan 23. pii: blood-2016-09-692582. doi: 10.1182/blood-2016-09-692582
    PubMed     Text format     Abstract available


  46. LAMY T, Moignet A, Loughran TP Jr
    LGL leukemia: from pathogenesis to treatment.
    Blood. 2017 Jan 23. pii: blood-2016-08-692590. doi: 10.1182/blood-2016-08-692590
    PubMed     Text format     Abstract available


  47. WATANABE T
    Adult T-cell leukemia (ATL): molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.
    Blood. 2017 Jan 23. pii: blood-2016-09-692574. doi: 10.1182/blood-2016-09-692574
    PubMed     Text format     Abstract available


  48. FINCH ER, Tukaramrao DB, Goodfield LL, Quickel MD, et al
    Activation of PPARgamma by endogenous prostaglandin J2 mediates the antileukemic effect of selenium in murine leukemia.
    Blood. 2017 Jan 23. pii: blood-2016-08-736405. doi: 10.1182/blood-2016-08-736405
    PubMed     Text format     Abstract available


  49. LANOCHA AA, Zdziarska B
    T-cell lymphoblastic leukemia with t(11;22)(q24;q12) and EWSR1 rearrangement.
    Blood. 2017;129:393.
    PubMed     Text format    


  50. DE WITTE T, Bowen D, Robin M, Malcovati L, et al
    Use of hematopoietic cell transplantation for patients with myelodysplastic syndrome and chronic myelomonocytic leukemia.
    Blood. 2017 Jan 17. pii: blood-2016-06-724500. doi: 10.1182/blood-2016-06-724500
    PubMed     Text format    


  51. WOYACH JA
    How I manage ibrutinib-refractory chronic lymphocytic leukemia.
    Blood. 2017 Jan 17. pii: blood-2016-09-693598. doi: 10.1182/blood-2016-09-693598
    PubMed     Text format     Abstract available


  52. MANTHA S, Goldman DA, Devlin SM, Lee JW, et al
    Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.
    Blood. 2017 Jan 12. pii: blood-2016-10-747170. doi: 10.1182/blood-2016-10-747170
    PubMed     Text format     Abstract available


  53. GANZEL C, Reinus C
    Nerves in bone marrow of newly diagnosed therapy-related acute myeloid leukemia.
    Blood. 2017;129:268.
    PubMed     Text format    


  54. XU Z, Beaulieu Bergeron M
    Near-triploid B lymphoblastic leukemia with Burkitt-like morphology.
    Blood. 2017;129:267.
    PubMed     Text format    


  55. KHATER F, Lajoie M, Langlois S, Healy J, et al
    KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia.
    Blood. 2017 Jan 9. pii: blood-2016-10-744219. doi: 10.1182/blood-2016-10-744219.
    PubMed     Text format    


  56. GOOSSENS S, Peirs S, Van Loocke W, Wang J, et al
    Oncogenic ZEB2 activation drives sensitivity towards KDM1A inhibition in T-cell acute lymphoblastic leukemia.
    Blood. 2017 Jan 9. pii: blood-2016-06-721191. doi: 10.1182/blood-2016-06-721191.
    PubMed     Text format     Abstract available


  57. POURABDOLLAH M, Chang H
    Plasma cell neoplasm with plasmablastic morphology mimicking acute leukemia.
    Blood. 2017;129:132.
    PubMed     Text format    


  58. LIU J, Guo B, Chen Z, Wang N, et al
    miR-125b promotes MLL-AF9-driven murine acute myeloid leukemia involving a VEGFA-mediated non-cell-intrinsic mechanism.
    Blood. 2017 Jan 4. pii: blood-2016-06-721027. doi: 10.1182/blood-2016-06-721027.
    PubMed     Text format     Abstract available


  59. CAO M, Li T, He Z, Wang L, et al
    Promyelocytic extracellular chromatin exacerbates coagulation and fibrinolysis in acute promyelocytic leukemia.
    Blood. 2017 Jan 4. pii: blood-2016-09-739334. doi: 10.1182/blood-2016-09-739334.
    PubMed     Text format     Abstract available


  60. AHN IE, Underbayev C, Albitar A, Herman SE, et al
    Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.
    Blood. 2017 Jan 3. pii: blood-2016-06-719294. doi: 10.1182/blood-2016-06-719294.
    PubMed     Text format     Abstract available


    December 2016
  61. RAIMBAULT A, Chapuis N
    Plasma cell leukemia revealing a G6PD deficiency.
    Blood. 2016;128:3178.
    PubMed     Text format    



  62. Huang ME, Ye YC, Chen SR, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988;72(2):567-572.
    Blood. 2016;128:3017.
    PubMed     Text format    


  63. KIM E, Hurtz C, Koehrer S, Wang Z, et al
    Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK.
    Blood. 2016 Dec 28. pii: blood-2016-06-722900. doi: 10.1182/blood-2016-06-722900
    PubMed     Text format     Abstract available


  64. MAXSON JE, Tyner JW
    Genomics of chronic neutrophilic leukemia.
    Blood. 2016 Dec 27. pii: blood-2016-10-695981. doi: 10.1182/blood-2016-10-695981
    PubMed     Text format     Abstract available



  65. Gallagher R, Collins S, Trujillo J, et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood. 1979;54(3):713-733.
    Blood. 2016;128:2871.
    PubMed     Text format    


  66. ABAZA Y, Kantarjian HM, Garcia-Manero G, Estey E, et al
    Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab.
    Blood. 2016 Dec 21. pii: blood-2016-09-736686. doi: 10.1182/blood-2016-09-736686
    PubMed     Text format     Abstract available


  67. NISS ARFELT K, Barington L, Benned-Jensen T, Kubale V, et al
    EBI2 overexpression in mice leads to B1 B cell expansion and chronic lymphocytic leukemia-(CLL)-like B cell malignancies.
    Blood. 2016 Dec 21. pii: blood-2016-02-697185. doi: 10.1182/blood-2016-02-697185
    PubMed     Text format     Abstract available


  68. QU Y, Siggens L, Cordeddu L, Gaidzik VI, et al
    Cancer specific changes in DNA methylation reveal aberrant silencing and activation of enhancers in leukemia.
    Blood. 2016 Dec 21. pii: blood-2016-07-726877. doi: 10.1182/blood-2016-07-726877
    PubMed     Text format     Abstract available



  69. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50(3):481-492.
    Blood. 2016;128:2745.
    PubMed     Text format    


  70. FRANCIS SS, Wallace AD, Wendt GA, Li L, et al
    In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia.
    Blood. 2016 Dec 15. pii: blood-2016-07-723148.
    PubMed     Text format     Abstract available


  71. AUBERGER P, Puissant A
    Autophagy, a key mechanism of oncogenesis and resistance in leukemia.
    Blood. 2016 Dec 12. pii: blood-2016-07-692707.
    PubMed     Text format     Abstract available


  72. POWELL JA, Lewis AC, Zhu W, Toubia J, et al
    Targeting sphingosine kinase 1 induces MCL1 dependent cell death in acute myeloid leukemia.
    Blood. 2016 Dec 12. pii: blood-2016-06-720433.
    PubMed     Text format     Abstract available


  73. REA D, Nicolini FE, Tulliez M, Guilhot F, et al
    Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study.
    Blood. 2016 Dec 8. pii: blood-2016-09-742205.
    PubMed     Text format     Abstract available


  74. BUNTING MD, Varelias A, Souza-Fonseca-Guimaraes F, Schuster IS, et al
    GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.
    Blood. 2016 Dec 7. pii: blood-2016-08-734020.
    PubMed     Text format     Abstract available


  75. JAIN N, Roberts KG, Jabbour E, Patel K, et al
    Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.
    Blood. 2016 Dec 5. pii: blood-2016-07-726588.
    PubMed     Text format     Abstract available


  76. LEONG SR, Sukumaran S, Hristopoulos M, Totpal K, et al
    An anti-CD3 / anti-CLL-1 Bispecific Antibody for the treatment of Acute Myeloid Leukemia.
    Blood. 2016 Dec 1. pii: blood-2016-08-735365.
    PubMed     Text format     Abstract available


    November 2016
  77. SAFAVI S, Paulsson K
    Near-haploid and low hypodiploid acute lymphoblastic leukemia - two distinct subtypes but consistently poor prognosis.
    Blood. 2016 Nov 30. pii: blood-2016-10-743765.
    PubMed     Text format     Abstract available


  78. GREVER MR, Abdel-Wahab O, Andritsos LA, Banerji V, et al
    Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.
    Blood. 2016 Nov 30. pii: blood-2016-01-689422.
    PubMed     Text format     Abstract available


  79. THEUNISSEN P, Mejstrikova E, Sedek L, van der Sluijs-Gelling AJ, et al
    Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia.
    Blood. 2016 Nov 30. pii: blood-2016-07-726307.
    PubMed     Text format     Abstract available


  80. GOTLIB J
    How I treat atypical chronic myeloid leukemia.
    Blood. 2016 Nov 29. pii: blood-2016-08-693630.
    PubMed     Text format     Abstract available



  81. Gill S, Tasian SK, Ruella M, et al. Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells. Blood. 2014;123(15):2343-2354.
    Blood. 2016;128:2585.
    PubMed     Text format    


  82. DANESHBOD Y, Medeiros LJ
    Pseudo Chediak-Higashi anomaly in acute monoblastic leukemia.
    Blood. 2016;128:2583.
    PubMed     Text format    


  83. THAKRAL B, Khoury JD
    Histiocytic sarcoma: secondary neoplasm or "transdifferentiation" in the setting of B-acute lymphoblastic leukemia.
    Blood. 2016;128:2475.
    PubMed     Text format    



  84. Thomas ED, Buckner CD, Banaji M, et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood. 1977;49(4):511-533.
    Blood. 2016;128:2373.
    PubMed     Text format    


  85. CUI B, Ghia EM, Chen L, Rassenti LZ, et al
    High-level ROR1 associates with accelerated disease-progression in chronic lymphocytic leukemia.
    Blood. 2016 Nov 4. pii: blood-2016-04-712562.
    PubMed     Text format     Abstract available


  86. ZHANG J, Kong G, Rajagopalan A, Lu L, et al
    p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemia.
    Blood. 2016 Nov 4. pii: blood-2016-06-719237.
    PubMed     Text format     Abstract available


  87. GOLDBERG AD, Tallman MS
    Down for the count in acute myeloid leukemia.
    Blood. 2016;128:2195-2197.
    PubMed     Text format    


  88. RYAN CE, Sahaf B, Logan AC, O'Brien S, et al
    Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT.
    Blood. 2016 Nov 1. pii: blood-2016-06-715284.
    PubMed     Text format     Abstract available


    October 2016

  89. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46(2):219-234.
    Blood. 2016;128:2109.
    PubMed     Text format    


  90. BRAIG F, Brandt A, Goebeler M, Tony HP, et al
    Resistance to anti-CD19/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking.
    Blood. 2016 Oct 26. pii: blood-2016-05-718395.
    PubMed     Text format     Abstract available


  91. MITANI K, Nagata Y, Sasaki K, Yoshida K, et al
    Somatic mosaicism in chronic myeloid leukemia in remission.
    Blood. 2016 Oct 26. pii: blood-2016-06-723494.
    PubMed     Text format    


  92. TASIAN SK, Teachey DT, Li Y, Shen F, et al
    Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia.
    Blood. 2016 Oct 24. pii: blood-2016-05-707653.
    PubMed     Text format     Abstract available



  93. Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975;45(3):321-334.
    Blood. 2016;128:1995.
    PubMed     Text format    


  94. LI H, Mar BG, Zhang H, Puram RV, et al
    The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia.
    Blood. 2016 Oct 18. pii: blood-2016-05-714493.
    PubMed     Text format     Abstract available


  95. BOTTONI A, Rizzotto L, Lai TH, Liu C, et al
    Targeting BTK through microRNA in chronic lymphocytic leukemia.
    Blood. 2016 Oct 17. pii: blood-2016-07-727750.
    PubMed     Text format     Abstract available


  96. KIM T, Tyndel MS, Kim HJ, Ahn JS, et al
    Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy.
    Blood. 2016 Oct 12. pii: blood-2016-04-708560.
    PubMed     Text format     Abstract available


  97. ANTONELLI A, Noort WA, Jaques J, de Boer B, et al
    Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based niches.
    Blood. 2016 Oct 12. pii: blood-2016-05-719021.
    PubMed     Text format     Abstract available


  98. BALL M, List AF, Padron E
    When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemia.
    Blood. 2016 Oct 5. pii: blood-2016-07-692988.
    PubMed     Text format     Abstract available


  99. MANCUSI A, Ruggeri L, Velardi A
    Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation.
    Blood. 2016 Oct 3. pii: blood-2016-07-730564.
    PubMed     Text format     Abstract available


  100. ANDERSSON E, Tanahashi T, Sekiguchi N, Gasparini VR, et al
    High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia.
    Blood. 2016 Oct 3. pii: blood-2016-06-724856.
    PubMed     Text format    


    September 2016
  101. DAGKLIS A, Demeyer S, De Bie J, Radaelli E, et al
    Hedgehog pathway activation in T-cell acute lymphoblastic leukemia predicts response to SMO and GLI1 inhibitors.
    Blood. 2016 Sep 30. pii: blood-2016-03-703454.
    PubMed     Text format     Abstract available



  102. Wang L, Man N, Sun X-J, et al. Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression. Blood. 2015;126(5):640-650.
    Blood. 2016;128:1778.
    PubMed     Text format    


  103. CHIANG MY, Wang Q, Gormley AC, Stein SJ, et al
    High selective pressure for Notch1 mutations that induce Myc in T cell acute lymphoblastic leukemia.
    Blood. 2016 Sep 26. pii: blood-2016-01-692855.
    PubMed     Text format     Abstract available


  104. KAJAL B, Chang H
    Acute myeloid leukemia with myelodysplasia-related changes demonstrating mixed-lineage phenotype.
    Blood. 2016;128:1663.
    PubMed     Text format    


  105. HU Z, Sun T
    Blastic plasmacytoid dendritic cell neoplasm associated with chronic myelomonocytic leukemia.
    Blood. 2016;128:1664.
    PubMed     Text format    


  106. KOTROVA M, Musilova A, Stuchly J, Fiser K, et al
    Distinct bilineal leukemia immunophenotypes are not genetically determined.
    Blood. 2016 Sep 13. pii: blood-2016-07-725861.
    PubMed     Text format    


  107. ZEBISCH A, Lal R, Muller M, Lind K, et al
    Acute myeloid leukemia with TP53 germline mutations.
    Blood. 2016 Sep 12. pii: blood-2016-08-732610.
    PubMed     Text format    


  108. DA CUNHA-BANG C, Christiansen I, Niemann CU
    The International prognostic Index for patients with chronic lymphocytic leukemia (CLL-IPI) applied in a population-based cohort.
    Blood. 2016 Sep 7. pii: blood-2016-07-724740.
    PubMed     Text format    


    August 2016
  109. DRUHAN LJ, McMahon DP, Steuerwald N, Price AE, et al
    Chronic neutrophilic leukemia in a child with a CSF3R T618I germline mutation.
    Blood. 2016 Aug 31. pii: blood-2016-07-730606.
    PubMed     Text format    


  110. FALINI B, Martelli MP, Tiacci E
    BRAF-V600E mutation in hairy cell leukemia: from bench to bedside.
    Blood. 2016 Aug 23. pii: blood-2016-07-418434.
    PubMed     Text format     Abstract available



  111. Ellison RR, Holland JF, Weil M, et al. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood. 1968;32(4):507-523.
    Blood. 2016;128:883.
    PubMed     Text format    


  112. FERREIRA TZ, Sandes AF
    Lymphocytosis, villi, and nucleoli: a variant of hairy cell leukemia.
    Blood. 2016;128:1018.
    PubMed     Text format    


  113. SPEEDY HE, Kinnersley B, Chubb D, Broderick P, et al
    Germline mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia.
    Blood. 2016 Aug 15. pii: blood-2016-01-695692.
    PubMed     Text format     Abstract available


  114. SUMITOMO Y, Koya J, Nakazaki K, Kataoka K, et al
    Cytoprotective autophagy maintains leukemia-initiating cells in murine myeloid leukemia.
    Blood. 2016 Aug 1. pii: blood-2015-12-684696.
    PubMed     Text format     Abstract available


    July 2016

  115. Dameshek W. Chronic lymphocytic leukemia-an accumulative disease of immunologically incompetent lymphocytes. Blood. 1967;29(4):566-584.
    Blood. 2016;128:465.
    PubMed     Text format    


  116. CAI Q, Jeannet R, Hua WK, Cook GJ, et al
    CBFbeta-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia-initiation in mice.
    Blood. 2016 Jul 21. pii: blood-2016-01-693119.
    PubMed     Text format     Abstract available


  117. HO TC, LaMere M, Stevens BM, Ashton JM, et al
    Evolution of acute myelogenous leukemia stem cell properties following treatment and progression.
    Blood. 2016 Jul 15. pii: blood-2016-02-695312.
    PubMed     Text format     Abstract available


  118. MIYOSHI H, Kiyasu J, Kato T, Yoshida N, et al
    PD-L1 expression on neoplastic or stromal cell is respectively poor or good prognostic factor for adult T-cell leukemia/lymphoma.
    Blood. 2016 Jul 14. pii: blood-2016-02-698936.
    PubMed     Text format     Abstract available


  119. MONTEWIS A, Eveillard M
    Acute myeloid leukemia with erythrophagocytosis indicative of KAT6A rearrangement.
    Blood. 2016;128:314.
    PubMed     Text format    


  120. ZHU H, Hu J, Chen L, Zhou W, et al
    The 12-year follow-up of survival, chronic adverse effects and retention of arsenic in patients with acute promyelocytic leukemia.
    Blood. 2016 Jul 11. pii: blood-2016-02-699439.
    PubMed     Text format    


  121. WOLLESCHAK D, Heidel FH
    Chronic myelogenous leukemia evolving after treatment of multiple myeloma.
    Blood. 2016;128:146.
    PubMed     Text format    


  122. ELENA C, Galli A, Such E, Meggendorfer M, et al
    Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.
    Blood. 2016 Jul 6. pii: blood-2016-05-714030.
    PubMed     Text format     Abstract available


    June 2016

  123. Whang J, Frei E III, Tjio JH, Carbone PP, Brecher G. The distribution of the Philadelphia chromosome in patients with chronic myelogenous leukemia. Blood. 1963;22(6):664-673.
    Blood. 2016;127:3295.
    PubMed     Text format    


  124. THOMPSON MP, Waters TM, Kaplan EK, McKillop CN, et al
    Hospital volume and acute myeloid leukemia mortality in Medicare beneficiaries aged 65 and older.
    Blood. 2016 Jun 29. pii: blood-2016-05-716662.
    PubMed     Text format    


  125. LIBOUREL EJ, Klerk CP, van Norden Y, de Maat MP, et al
    Disseminated intravascular coagulation at diagnosis is a strong predictor for both arterial and venous thrombosis in newly diagnosed acute myeloid leukemia.
    Blood. 2016 Jun 28. pii: blood-2016-02-701094.
    PubMed     Text format     Abstract available


  126. RASHIDI A, Walter RB, Tallman MS, Appelbaum FR, et al
    Maintenance therapy in acute myeloid leukemia: an evidence-based review of randomized trials.
    Blood. 2016 Jun 27. pii: blood-2016-03-674127.
    PubMed     Text format    


  127. RAU RE, Rodriguez B, Luo M, Jeong M, et al
    DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
    Blood. 2016 Jun 22. pii: blood-2015-11-684225.
    PubMed     Text format     Abstract available


  128. LEIVA-JUAREZ MM, Ware HH, Kulkarni VV, Zweidler-McKay PA, et al
    Inducible epithelial resistance protects mice against leukemia-associated pneumonia.
    Blood. 2016 Jun 17. pii: blood-2016-03-708511.
    PubMed     Text format     Abstract available


  129. KOSCIUCZUK EM, Saleiro D, Kroczynska B, Beauchamp EM, et al
    Merestinib blocks MNK kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo.
    Blood. 2016 Jun 15. pii: blood-2016-02-698704.
    PubMed     Text format     Abstract available


  130. METZELER KH, Herold T, Rothenberg-Thurley M, Amler S, et al
    Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.
    Blood. 2016 Jun 10. pii: blood-2016-01-693879.
    PubMed     Text format     Abstract available


  131. GREVER MR
    BRAF inhibitor: targeted therapy in hairy cell leukemia.
    Blood. 2016;127:2784-5.
    PubMed     Text format    


  132. PIYA S, Kornblau SM, Ruvolo VR, Mu H, et al
    Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia.
    Blood. 2016 Jun 7. pii: blood-2016-01-692244.
    PubMed     Text format     Abstract available


    May 2016
  133. LAMPSON BL, Kasar SN, Matos TR, Morgan EA, et al
    Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity.
    Blood. 2016 May 31. pii: blood-2016-03-707133.
    PubMed     Text format     Abstract available


  134. SHORT NJ, Jabbour E, Sasaki K, Patel K, et al
    Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Blood. 2016 May 27. pii: blood-2016-03-707562.
    PubMed     Text format     Abstract available


  135. THIJSSEN R, Ter Burg J, Garrick B, van Bochove GG, et al
    Dual TORK/DNA-PK inhibition blocks critical signalling pathways in chronic lymphocytic leukemia.
    Blood. 2016 May 27. pii: blood-2016-02-700328.
    PubMed     Text format     Abstract available


  136. OFRAN Y, Tallman MS, Rowe JM
    How I treat acute myeloid leukemia presenting with preexisting comorbidities.
    Blood. 2016 May 27. pii: blood-2016-01-635060.
    PubMed     Text format     Abstract available


  137. THORNE SH
    Virus fuels NK cell killing of leukemia.
    Blood. 2016;127:2509.
    PubMed     Text format    


  138. GUO B, Zhang L, Chiorazzi N, Rothstein TL, et al
    IL-4 rescues surface IgM expression in chronic lymphocytic leukemia.
    Blood. 2016 May 25. pii: blood-2015-11-682997.
    PubMed     Text format     Abstract available


  139. ELMAAGACLI AH, Koldehoff M
    Cytomegalovirus replication reduces the relapse incidence in patients with acute myeloid leukemia.
    Blood. 2016 May 23. pii: blood-2016-04-713644.
    PubMed     Text format    


  140. HANDGRETINGER R, Lang P, Andre MC
    Exploitation of Natural Killer (NK) cells for the treatment of acute leukemia.
    Blood. 2016 May 20. pii: blood-2015-12-629055.
    PubMed     Text format     Abstract available


  141. BAHMANYAR M, Chang H
    Acute myeloid leukemia with myelodysplasia-related changes demonstrating prominent basophilic differentiation.
    Blood. 2016;127:2503.
    PubMed     Text format    


  142. RASHIDI A, Fisher SI
    EBV-associated aggressive natural killer cell leukemia.
    Blood. 2016;127:2502.
    PubMed     Text format    


  143. MOORE EM, Roth CG
    Plasma cell leukemia mimicking acute myeloid leukemia.
    Blood. 2016;127:2359.
    PubMed     Text format    



  144. Heyssel R, Brill AB, Woodbury LA, et al. Leukemia in Hiroshima atomic bomb survivors. Blood. 1960;15(3):313-331.
    Blood. 2016;127:2165.
    PubMed     Text format    


    April 2016
  145. SMALLWOOD DT, Apollonio B, Willimott S, Lezina L, et al
    Extracellular vesicles released by CD40/IL-4 stimulated chronic lymphocytic leukemia cells confer altered functional properties to CD4+ T cells.
    Blood. 2016 Apr 26. pii: blood-2015-11-682377.
    PubMed     Text format     Abstract available


  146. MA HS, Greenblatt SM, Shirley CM, Duffield AS, et al
    All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo.
    Blood. 2016 Apr 21. pii: blood-2015-05-646786.
    PubMed     Text format     Abstract available


  147. WILLIAMS MT, Yousafzai YM, Elder A, Rehe K, et al
    The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.
    Blood. 2016;127:1998-2006.
    PubMed     Text format     Abstract available


  148. MICHEL G, Galambrun C, Sirvent A, Pochon C, et al
    Single versus double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome.
    Blood. 2016 Apr 20. pii: blood-2016-01-694349.
    PubMed     Text format     Abstract available


  149. JOHNSON SM, Dempsey C, Chadwick A, Harrison S, et al
    Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia.
    Blood. 2016 Apr 20. pii: blood-2015-12-688051.
    PubMed     Text format    


  150. PARKER WT, Yeung DT, Yeoman AL, Altamura HK, et al
    The impact of multiple low-level BCR-ABL1 mutations on response to ponatinib.
    Blood. 2016;127:1870-80.
    PubMed     Text format     Abstract available


  151. ARBER DA, Orazi A, Hasserjian R, Thiele J, et al
    The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia.
    Blood. 2016 Apr 11. pii: blood-2016-03-643544.
    PubMed     Text format     Abstract available


  152. BAZARBACHI A
    Tax fingerprint in adult T-cell leukemia.
    Blood. 2016;127:1737-8.
    PubMed     Text format    


  153. PARIKH SA, Strati P, Tsang M, West CP, et al
    Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? A systematic review and meta-analysis.
    Blood. 2016;127:1752-60.
    PubMed     Text format     Abstract available


  154. GU S, Chan WW, Mohi G, Rosenbaum J, et al
    Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1.
    Blood. 2016;127:1803-13.
    PubMed     Text format     Abstract available


    March 2016

  155. Frei E III, Holland JF, Schneiderman MA, et al. A comparative study of two regimens of combination chemotherapy in acute leukemia. Blood. 1958;13(12):1126-1148.
    Blood. 2016;127:1621.
    PubMed     Text format    


  156. REDELL MS
    A STAT3 decoy lures AML out of hiding.
    Blood. 2016;127:1628-9.
    PubMed     Text format     Abstract available



  157. Bouroncle BA, Wiseman BK, Doan CA. Leukemic reticuloendotheliosis. Blood. 1958;13(7):609-630.
    Blood. 2016;127:1519.
    PubMed     Text format     Abstract available


  158. LUSKIN MR, Lee JW, Fernandez HF, Abdel-Wahab O, et al
    Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups.
    Blood. 2016;127:1551-8.
    PubMed     Text format     Abstract available


  159. SCHULZE I, Rohde C, Scheller-Wendorff M, Baumer N, et al
    Increased DNA methylation of Dnmt3b targets impairs leukemogenesis.
    Blood. 2016;127:1575-86.
    PubMed     Text format     Abstract available


  160. STANLEY RF, Steidl U
    Ectopic DNMT3B expression delays leukemogenesis.
    Blood. 2016;127:1525-6.
    PubMed     Text format     Abstract available


  161. BABA T, Tanabe Y, Yoshikawa S, Yamanishi Y, et al
    MIP-1alpha/CCL3-expressing basophil-lineage cells drive the leukemic hematopoiesis of chronic myeloid leukemia in mice.
    Blood. 2016 Mar 22. pii: blood-2015-10-673087.
    PubMed     Text format     Abstract available


  162. WANG W, Cortes JE, Tang G, Khoury JD, et al
    Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.
    Blood. 2016 Mar 22. pii: blood-2016-01-690230.
    PubMed     Text format     Abstract available


  163. WANQUET A, Birsen R, Lemal R, Hunault M, et al
    Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemia.
    Blood. 2016 Mar 18. pii: blood-2016-02-697193.
    PubMed     Text format    


  164. KADIA TM
    Release the hounds: virotherapy with immunotherapy.
    Blood. 2016;127:1381-3.
    PubMed     Text format     Abstract available


  165. DUPLOYEZ N, Marceau-Renaut A, Boissel N, Petit A, et al
    Comprehensive mutational profiling of core binding factor acute myeloid leukemia.
    Blood. 2016 Mar 15. pii: blood-2015-12-688705.
    PubMed     Text format     Abstract available


  166. NEESON P
    Allogeneic CAR19 cells clear ALL.
    Blood. 2016;127:1224-5.
    PubMed     Text format     Abstract available



  167. Rosenthal MC, Pisciotta AV, Komninos ZD, Goldenberg H, Dameshek W. The auto-immune hemolytic anemia of malignant lymphocytic disease. Blood. 1955;10(3):197-227.
    Blood. 2016;127:1217.
    PubMed     Text format    


  168. JACOBY E, Yang Y, Qin H, Chien CD, et al
    Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD.
    Blood. 2016;127:1361-70.
    PubMed     Text format     Abstract available


  169. MAN N, Sun XJ, Tan Y, Garcia-Cao M, et al
    Differential role of Id1 in MLL-AF9-driven leukemia based on cell of origin.
    Blood. 2016 Mar 4. pii: blood-2015-11-677708.
    PubMed     Text format     Abstract available


  170. DIETRICH S, Pircher A, Endris V, Peyrade F, et al
    BRAF inhibition in hairy cell leukemia with low dose vemurafenib.
    Blood. 2016 Mar 3. pii: blood-2015-11-680074.
    PubMed     Text format     Abstract available


    February 2016
  171. OLOMBEL G, Guerin E, Guy J, Perrot JY, et al
    The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia.
    Blood. 2016 Feb 29. pii: blood-2016-01-689976.
    PubMed     Text format    


  172. CHEN Z, Hu S
    MYC/BCL2 double-hit lymphoma/leukemia mimicking acute leukemia at initial presentation.
    Blood. 2016;127:1072.
    PubMed     Text format    


  173. TAWANA K, Fitzgibbon J
    Inherited DDX41 mutations: 11 genes and counting.
    Blood. 2016;127:960-1.
    PubMed     Text format    


  174. BLACHLY JS
    Ribosomal revelation.
    Blood. 2016;127:958-9.
    PubMed     Text format    


  175. LEWINSOHN M, Brown AL, Weinel LM, Phung C, et al
    Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.
    Blood. 2016;127:1017-23.
    PubMed     Text format     Abstract available


  176. MARCUCCI G, Li L
    Not only TKI! Targeting FLT3-ITD by autophagy.
    Blood. 2016;127:796-7.
    PubMed     Text format    


  177. WONG TN, Miller CA, Klco JM, Petti A, et al
    Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML.
    Blood. 2016;127:893-7.
    PubMed     Text format     Abstract available


  178. LARRUE C, Saland E, Boutzen H, Vergez F, et al
    Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells.
    Blood. 2016;127:882-92.
    PubMed     Text format     Abstract available


  179. DEININGER MW, Hodgson JG, Shah NP, Cortes JE, et al
    Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients.
    Blood. 2016;127:703-12.
    PubMed     Text format     Abstract available


  180. SAGLIO G, Fava C
    BCR-ABL1 mutation not equal ponatinib resistance.
    Blood. 2016;127:666-7.
    PubMed     Text format    


  181. MARTINEZ-TRILLOS A, Navarro A, Aymerich M, Delgado J, et al
    Clinical impact of MYD88 mutations in chronic lymphocytic leukemia.
    Blood. 2016 Feb 4. pii: blood-2015-10-678490.
    PubMed     Text format    


  182. ISHIKAWA S
    Opposite RHOA functions within the ATLL category.
    Blood. 2016;127:524-5.
    PubMed     Text format     Abstract available


  183. NADEU F, Delgado J, Royo C, Baumann T, et al
    Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1 and ATM mutations in chronic lymphocytic leukemia.
    Blood. 2016 Feb 2. pii: blood-2015-07-659144.
    PubMed     Text format     Abstract available


  184. PABST C, Bergeron A, Lavallee VP, Yeh J, et al
    GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo.
    Blood. 2016 Feb 1. pii: blood-2015-11-683649.
    PubMed     Text format     Abstract available


    January 2016
  185. VALSECCHI R, Coltella N, Belloni D, Ponente M, et al
    HIF-1alpha regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment.
    Blood. 2016 Jan 29. pii: blood-2015-07-657056.
    PubMed     Text format     Abstract available


  186. PAGGETTI J, Moussay E
    BCR engagement in CLL: when translation goes wrong.
    Blood. 2016;127:378-80.
    PubMed     Text format     Abstract available


  187. MAUS MV
    Innate immune signaling in CLL.
    Blood. 2016;127:376-8.
    PubMed     Text format     Abstract available


  188. WALTER HS, Rule SA, Dyer MJ, Karlin L, et al
    A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies.
    Blood. 2016;127:411-9.
    PubMed     Text format     Abstract available


  189. WAGNER M, Oelsner M, Moore A, Gotte F, et al
    Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemia.
    Blood. 2016;127:436-48.
    PubMed     Text format     Abstract available


  190. BELLON M, Lu L, Nicot C
    Constitutive activation of Pim1 kinase is a therapeutic target for adult T-cell leukemia.
    Blood. 2016 Jan 26. pii: blood-2015-11-685032.
    PubMed     Text format     Abstract available


  191. FRAIETTA JA, Beckwith KA, Patel PR, Ruella M, et al
    Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia.
    Blood. 2016 Jan 26. pii: blood-2015-11-679134.
    PubMed     Text format     Abstract available


  192. ZHANG Q, Hossain DM, Duttagupta P, Moreira D, et al
    Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia.
    Blood. 2016 Jan 21. pii: blood-2015-08-665604.
    PubMed     Text format     Abstract available



  193. Farber S. Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer. Blood. 1949;4(2):160-167.
    Blood. 2016;127:271.
    PubMed     Text format    


  194. AWAN FT
    Cure for CLL?
    Blood. 2016;127:274.
    PubMed     Text format    


  195. THOMPSON PA, Wierda WG
    Eliminating minimal residual disease as a therapeutic end point: working toward cure for patients with CLL.
    Blood. 2016;127:279-86.
    PubMed     Text format     Abstract available


  196. LIBURA M, Giebel S, Piatkowska-Jakubas B, Pawelczyk M, et al
    Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients.
    Blood. 2016;127:360-2.
    PubMed     Text format    


  197. FUJIKAWA D, Nakagawa S, Hori M, Kurokawa N, et al
    Polycomb-dependent epigenetic landscape in adult T-cell leukemia.
    Blood. 2016 Jan 15. pii: blood-2015-08-662593.
    PubMed     Text format     Abstract available


  198. MINUCCI S
    DNA binding modes of leukemia oncoproteins.
    Blood. 2016;127:177-8.
    PubMed     Text format    


  199. ARNOUX I, Loosveld M
    Hepatosplenic T-cell lymphoma: an acute leukemia presentation.
    Blood. 2016;127:269.
    PubMed     Text format    


  200. WOYACH JA
    FCR holds up to the test of time: CLL8 follow-up.
    Blood. 2016;127:172-3.
    PubMed     Text format    


  201. LIU J, Zhu HH, Jiang H, Jiang Q, et al
    Varying responses of PML-RARA with different genetic mutations to arsenic trioxide.
    Blood. 2016;127:243-50.
    PubMed     Text format     Abstract available


  202. FISCHER K, Bahlo J, Fink AM, Goede V, et al
    Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial.
    Blood. 2016;127:208-15.
    PubMed     Text format     Abstract available


  203. MIRANTES C, Dosil MA, Hills D, Yang J, et al
    Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma, but not myeloid malignancies.
    Blood. 2016 Jan 14. pii: blood-2015-09-669036.
    PubMed     Text format     Abstract available


  204. JAIN N, Lamb AE, O'Brien S, Ravandi F, et al
    Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.
    Blood. 2016 Jan 8. pii: blood-2015-08-661702.
    PubMed     Text format     Abstract available


  205. BURGER JA
    Obinutuzumab: the more the merrier?
    Blood. 2016;127:6-8.
    PubMed     Text format     Abstract available


  206. STEIN EM, Tallman MS
    Emerging therapeutic drugs for AML.
    Blood. 2016;127:71-8.
    PubMed     Text format     Abstract available


  207. AL-HUSSAINI M, Rettig MP, Ritchey JK, Karpova D, et al
    Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platform.
    Blood. 2016;127:122-31.
    PubMed     Text format     Abstract available


  208. JAIN P, Kantarjian H, Patel KP, Nogueras Gonzalez G, et al
    Impact of BCR-ABL transcript type on response and survival in patients with chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors.
    Blood. 2016 Jan 4. pii: blood-2015-10-674242.
    PubMed     Text format     Abstract available


    December 2015
  209. HELSMOORTEL HH, Bresolin S, Lammens T, Cave H, et al
    LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia.
    Blood. 2015 Dec 28. pii: blood-2015-09-667808.
    PubMed     Text format     Abstract available


  210. SHEN W, Patnaik MM, Ruiz A, Russell SJ, et al
    Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia.
    Blood. 2015 Dec 28. pii: blood-2015-06-652503.
    PubMed     Text format     Abstract available


  211. ISLAM P, Daniel C, Strelec L, Kaye AH, et al
    Ibrutinib-induced pneumonitis in patients with chronic lymphocytic leukemia.
    Blood. 2015 Dec 23. pii: blood-2015-12-686873.
    PubMed     Text format    


  212. LJUNGSTROM V, Cortese D, Young E, Pandzic T, et al
    Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.
    Blood. 2015 Dec 16. pii: blood-2015-10-674572.
    PubMed     Text format     Abstract available


  213. WOUTERS BJ, Delwel R
    Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia.
    Blood. 2015 Dec 10. pii: blood-2015-07-604512.
    PubMed     Text format     Abstract available


  214. GRIMWADE D, Ivey A, Huntly BJ
    Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance.
    Blood. 2015 Dec 10. pii: blood-2015-07-604496.
    PubMed     Text format     Abstract available


  215. LOWENBERG B, Rowe JM
    Introduction to the Review Series on Advances in Acute Myeloid Leukemia (AML).
    Blood. 2015 Dec 10. pii: blood-2015-10-662684.
    PubMed     Text format    


  216. DOMBRET H, Gardin C
    An update of current treatments for adult acute myeloid leukemia.
    Blood. 2015 Dec 10. pii: blood-2015-08-604520.
    PubMed     Text format     Abstract available


  217. CORNELISSEN JJ, Blaise D
    Hematopoietic stem cell transplantation for patients with AML in first CR.
    Blood. 2015 Dec 10. pii: blood-2015-07-604546.
    PubMed     Text format     Abstract available


  218. UTTARKAR S, Dasse E, Coulibaly A, Steinmann S, et al
    Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction.
    Blood. 2015 Dec 2. pii: blood-2015-09-668632.
    PubMed     Text format     Abstract available


    November 2015
  219. KUCINE N, Marubayashi S, Bhagwat N, Papalexi E, et al
    Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias.
    Blood. 2015;126:2479-83.
    PubMed     Text format     Abstract available


  220. KAROL SE, Mattano LA Jr, Yang W, Maloney KW, et al
    Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia.
    Blood. 2015 Nov 20. pii: blood-2015-10-673848.
    PubMed     Text format     Abstract available


  221. LIU H, Sun X
    Pleomorphic plasma cell leukemia.
    Blood. 2015;126:2436.
    PubMed     Text format    


  222. LARSON RA
    Is there a best TKI for chronic phase CML?
    Blood. 2015;126:2370-5.
    PubMed     Text format     Abstract available


  223. STEENSMA DP
    Cytopenias + mutations - dysplasia = what?
    Blood. 2015;126:2349-51.
    PubMed     Text format    


  224. MATTHEWS GM, Mehdipour P, Cluse LA, Falkenberg KJ, et al
    Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies.
    Blood. 2015;126:2392-403.
    PubMed     Text format     Abstract available


  225. CARGO CA, Rowbotham N, Evans PA, Barrans SL, et al
    Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression.
    Blood. 2015;126:2362-5.
    PubMed     Text format     Abstract available


  226. VERHAGEN HJ, Smit MA, Rutten A, Denkers F, et al
    Primary acute myeloid leukemia cells with overexpression of EVI-1 are sensitive to all trans retinoic acid.
    Blood. 2015 Nov 18. pii: blood-2015-07-653840.
    PubMed     Text format     Abstract available


  227. OROZCO JJ, Kenoyer A, Balkin ER, Gooley TA, et al
    Anti-CD45 radioimmunotherapy without TBI before BMT facilitates persistent haploidentical donor engraftment in a murine model.
    Blood. 2015 Nov 17. pii: blood-2014-12-617019.
    PubMed     Text format     Abstract available


  228. NAGATA Y, Kontani K, Enami T, Kataoka K, et al
    Variegated RHOA mutations in adult T-cell leukemia/lymphoma.
    Blood. 2015 Nov 16. pii: blood-2015-06-644948.
    PubMed     Text format     Abstract available


  229. KWOK M, Davies N, Agathanggelou A, Smith E, et al
    ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53 or ATM defective chronic lymphocytic leukemia cells.
    Blood. 2015 Nov 12. pii: blood-2015-05-644872.
    PubMed     Text format     Abstract available


  230. ARANGO M
    Adult T-cell leukemia/lymphoma.
    Blood. 2015;126:2343.
    PubMed     Text format    


  231. BOSCH F, Abrisqueta P
    Ibrutinib in CLL: 2 sides of the same coin.
    Blood. 2015;126:2173-4.
    PubMed     Text format    


    October 2015
  232. ZENZ T, Huber W
    Mutational landscape and complexity in CLL.
    Blood. 2015;126:2078-9.
    PubMed     Text format    


  233. GUIEZE R, Robbe P, Clifford R, de Guibert S, et al
    Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.
    Blood. 2015;126:2110-7.
    PubMed     Text format     Abstract available


  234. LANDGREN O
    No CLL transmission through blood transfusion.
    Blood. 2015;126:1978-9.
    PubMed     Text format     Abstract available


  235. LI Z, Chen P, Su R, Li Y, et al
    Overexpression and knockout of miR-126 both promote leukemogenesis.
    Blood. 2015;126:2005-15.
    PubMed     Text format     Abstract available


  236. SCHMID C, Labopin M, Socie G, Daguindau E, et al
    Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation.
    Blood. 2015;126:2062-9.
    PubMed     Text format     Abstract available


  237. DEBORD C, Eveillard M
    Leukemic phase of a large B-cell lymphoma arising in KSHV-associated multicentric Castleman disease.
    Blood. 2015;126:1966.
    PubMed     Text format    


  238. EVEILLARD M, Moreau P
    Atypical plasma cell leukemia mistaken for lymphocytosis on blood count.
    Blood. 2015;126:1965.
    PubMed     Text format    


  239. SAMUDIO I, Konopleva M
    Targeting leukemia's "fatty tooth".
    Blood. 2015;126:1874-5.
    PubMed     Text format     Abstract available


  240. DEARDEN C
    So FCR, so good.
    Blood. 2015;126:1872-4.
    PubMed     Text format     Abstract available


  241. GAYNON PS
    ALL and osteonecrosis.
    Blood. 2015;126:1734-5.
    PubMed     Text format     Abstract available


  242. HWANG IS, Shin S, Min YH, Lee ST, et al
    NOTCH2 missplicing can occur in relation to apoptosis.
    Blood. 2015;126:1731-2.
    PubMed     Text format    


  243. PLESA A, Sujobert P
    This is not an erythroblast.
    Blood. 2015;126:1729.
    PubMed     Text format    


    September 2015
  244. OSHIMA M, Iwama A
    Nuclear, not cytoplasmic, PKR maneuvers in AML.
    Blood. 2015;126:1523-4.
    PubMed     Text format     Abstract available


  245. SPERLAZZA J, Rahmani M, Beckta J, Aust M, et al
    Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation.
    Blood. 2015;126:1462-72.
    PubMed     Text format     Abstract available


  246. ORTUNO FJ, Sola M
    Extreme dyserythropoiesis in the setting of acute erythroid leukemia.
    Blood. 2015;126:1391.
    PubMed     Text format    


  247. EMADI A
    Exploiting AML vulnerability: glutamine dependency.
    Blood. 2015;126:1269-70.
    PubMed     Text format    


  248. CALIGARIS-CAPPIO F
    Directing CLL-cell traffic.
    Blood. 2015;126:1267-8.
    PubMed     Text format    


  249. SERODY J
    GVHD and miR: good things in small packages.
    Blood. 2015;126:1265-7.
    PubMed     Text format    


  250. MUKHERJEE S
    "Blood feuds".
    Blood. 2015;126:1264-5.
    PubMed     Text format    


  251. OCHODNICKA-MACKOVICOVA K, Bahjat M, Bloedjes TA, Maas C, et al
    NF-kappaB and AKT signaling prevent DNA damage in transformed pre-B cells by suppressing RAG1/2 expression and activity.
    Blood. 2015;126:1324-35.
    PubMed     Text format     Abstract available


    August 2015
  252. APOLLONIO B, Ramsay AG
    Exosomes and CAFs: partners in crime.
    Blood. 2015;126:1053-5.
    PubMed     Text format     Abstract available


  253. MAHIEUX R
    A vaccine against HTLV-1 HBZ makes sense.
    Blood. 2015;126:1052-3.
    PubMed     Text format     Abstract available


  254. SUGATA K, Yasunaga J, Mitobe Y, Miura M, et al
    Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor.
    Blood. 2015;126:1095-105.
    PubMed     Text format     Abstract available


    July 2015
  255. CHENG H, Hao S, Liu Y, Pang Y, et al
    Leukemic marrow infiltration reveals a novel role for Egr3 as a potent inhibitor of normal hematopoietic stem cell proliferation.
    Blood. 2015 Jul 17. pii: blood-2015-01-623645.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: